Pyroptosis in Periprosthetic Osteolysis

Area of Science:

• Biomedical Engineering
• Immunology
• Orthopedics

Background:

• Periprosthetic osteolysis (PPO) and aseptic loosening (AL) are primary causes of artificial joint failure, necessitating revision surgery.
• The exact molecular mechanisms driving PPO are not fully understood, but aseptic inflammation induced by wear particles is implicated.
• This inflammation disrupts the balance between bone formation and resorption, mediated by osteoblasts and osteoclasts, respectively.

Purpose of the Study:

• To review the pathological processes involved in periprosthetic osteolysis (PPO).
• To elucidate the molecular mechanisms of pyroptosis, a regulated cell death pathway.
• To explore interventions targeting inflammation and pyroptosis in PPO.

Main Methods:

• Literature review focusing on the pathological mechanisms of PPO.
• Analysis of the role of pyroptosis, particularly involving gasdermin D (GSDMD) and NLRP3 inflammasomes.
• Examination of cellular responses and potential therapeutic strategies.

Main Results:

• Recent evidence suggests that NLRP3 inflammasome activation and subsequent pyroptosis are critical in the pathogenesis of PPO.
• Pyroptosis contributes to the inflammatory environment that favors bone resorption over formation.
• Various cellular interventions can potentially inhibit inflammation and pyroptosis in PPO.

Conclusions:

• Pyroptosis plays a significant role in the inflammatory cascade leading to periprosthetic osteolysis (PPO).
• Targeting pyroptosis and associated inflammation presents a promising therapeutic avenue for PPO.
• This review provides a foundation for developing novel treatment strategies and identifying new therapeutic targets for PPO.